Neuroptix, Inc. Obtains $18,500,000 Series B Financing

  • Feed Type
  • Date
    10/22/2008
  • Company Name
    Neuroptix, Inc.
  • Mailing Address
    20 Main Street Acton, MA 01720
  • Company Description
    Neuroptix develops, manufactures and distributes state-of-the-art products for extremely sensitive measurements of biophysical changes in the eye, including non-invasive instruments for diagnosis and monitoring Alzheimer’s disease undergoing clinical development. Adaptable and innovative, Neuroptix’s products are designed for a variety of research environments including academic and pharmaceutical laboratories. Neuroptix is also developing diagnostic agents for application in screening tests for Alzheimer’s disease and prion diseases.
  • Website
    http://www.neuroptix.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $18,500,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Undisclosed
  • M&A Terms
  • Venture Investor
    Inventages Venture Capital
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.